CLINICAL_TRIALS
trial_result
· 2022-11-03
Clinical Trial Update: OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers [Phase 4]
Summary
Phase 4 trial update evaluating OC-01 (varenicline) nasal spray for dry eye signs and symptoms in daily disposable contact lens wearers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Center for Ophthalmic and Vision Research, LLC | Conditions: Dry Eye | Phase 4 | Status: COMPLETED